Carlos Pato, MD, PhD, is Vice President of Research, Training and Academic Affairs for Rutgers University Behavioral Health Care (UBHC) and the Executive Chair of Psychiatry for Rutgers RBHS. Much of Dr. Carlos Pato’s work is related to social determinants of health. His research has focused on genomic psychiatry, with an emphasis on population-based genetic studies. Prior to Dr. Carlos Pato’s experience with the Institute for Genomic Health, he served for three-and-a-half years as senior vice president and dean of the College of Medicine at SUNY Downstate, doubling the number of affiliated hospital beds and affiliated faculty, and developing a focus on primary care, as well as building up research on population health and disparities, with a focus on genomics and social determinants of health. Previously, he served as chair of Psychiatry at the University of Southern California’s Keck School of Medicine, where, under his leadership, the clinical program grew 350 percent, the research program grew from two to 13 NIH-funded investigators and NIH funding grew 10-fold, while philanthropic support grew 15-fold.
A graduate of the University of Cincinnati College of Medicine, Dr. Carlos Pato received an honorary doctorate in medical genetics from Universidade de Coimbra, Portugal, where he has served as a visiting scientist and co-lead of the Unit for Neuropsychiatric Genetics since 1990. He completed his residency training in psychiatry at Massachusetts General Hospital, Boston, and subsequently served as a research fellow at the National Institute of Mental Health, Bethesda, Md.
Dr. Carlos Pato is a distinguished fellow of the American Psychiatric Association and a charter member of the International Society of Psychiatric Genetics and has held leadership positions with the American Association of Chairs of Departments of Psychiatry, among his many professional associations.
A co-editor of Revista Brasileira de Psiguiatria and field editor of the American Journal of Genetics, Dr. Carlos Pato also serves on the editorial board of Translational Psychiatry and as a reviewer for nearly a dozen peer-reviewed professional journals. He has nearly 200 peer-reviewed articles to his credit, as well as publications in other journals, book chapters and a book.